Colleen Harris - Ramsay Health Group Officer
| RMY Stock | EUR 23.20 0.20 0.87% |
Insider
Colleen Harris is Group Officer of Ramsay Health Care
| Age | 54 |
| Phone | 61 2 9220 1000 |
| Web | https://www.ramsayhealth.com |
Ramsay Health Management Efficiency
The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0882 %, meaning that it generated $0.0882 on every $100 dollars invested by stockholders. Ramsay Health's management efficiency ratios could be used to measure how well Ramsay Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mike Taylor | Identiv | N/A | |
| Sven Pettersson | SIVERS SEMICONDUCTORS AB | 60 | |
| Bjorn Norrbom | SIVERS SEMICONDUCTORS AB | 72 | |
| Ingrid Engstrom | SIVERS SEMICONDUCTORS AB | 59 | |
| David Bullock | Origin Agritech | 49 | |
| Michael Trimble | Origin Agritech | 56 | |
| Caroline Schlienkamp | Talanx AG | 49 | |
| Wilm Langenbach | Talanx AG | 52 | |
| James Devens | Superior Plus Corp | N/A | |
| Christopher Lohmann | Talanx AG | 55 | |
| Leigh Dow | Identiv | N/A | |
| Robert Smith | NMI Holdings | 53 | |
| Dag Sigurd | SIVERS SEMICONDUCTORS AB | 73 | |
| Edward Kirnbauer | Identiv | 58 | |
| JeanJacques Henchoz | Talanx AG | 59 | |
| Edgar Puls | Talanx AG | 50 | |
| Tomas Duffy | SIVERS SEMICONDUCTORS AB | 62 | |
| Ravi Mallela | NMI Holdings | 53 | |
| Erik Wiklund | SIVERS SEMICONDUCTORS AB | 49 | |
| Gengchen Han | Origin Agritech | 58 | |
| Steve Dunlap | Identiv | N/A | |
Management Performance
| Return On Equity | 0.0882 | |||
| Return On Asset | 0.0155 |
Ramsay Health Care Leadership Team
Elected by the shareholders, the Ramsay Health's board of directors comprises two types of representatives: Ramsay Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ramsay. The board's role is to monitor Ramsay Health's management team and ensure that shareholders' interests are well served. Ramsay Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ramsay Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Wearne, Global Exec | ||
| LLB BECON, Group Sec | ||
| Kelly Hibbins, Group Relations | ||
| Andrew Jones, Group Officer | ||
| Craig McNally, MD CEO | ||
| Martyn Roberts, Group Officer | ||
| Colleen Harris, Group Officer | ||
| AC DSc, Group Officer | ||
| Doug Meagher, CFO Australia | ||
| Kah Hong, Group Care |
Ramsay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ramsay Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0882 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 16.3 B | |||
| Shares Outstanding | 228.88 M | |||
| Shares Owned By Insiders | 21.51 % | |||
| Shares Owned By Institutions | 24.01 % | |||
| Price To Earning | 32.73 X | |||
| Price To Book | 3.85 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Ramsay Stock
Ramsay Health financial ratios help investors to determine whether Ramsay Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ramsay with respect to the benefits of owning Ramsay Health security.